Safety of direct oral anticoagulants in surgical bioprosthetic heart valves: a paediatric institution’s experience
We observed a higher overall bleeding rate, driven predominately by clinically relevant non-major bleeding events, than other studies using short-term anticoagulation after surgical pulmonary valve replacement. Additional studies should be aimed at evaluating the dosing and safety of direct oral anticoagulants in children in the post-operative period.
Authors
- Gary Woods (ORCID: https://orcid.org/0000-0002-0921-0974)
- Michelle E. Gleason (ORCID: https://orcid.org/0000-0002-5889-2676)
- Joshua W. Branstetter (ORCID: https://orcid.org/0000-0002-6637-625X)
- Joshua Rosenblum
- Gwen Nance
- Michael P. Fundora (ORCID: https://orcid.org/0000-0003-3204-1176)
- Paul J. Chai
- Daniela Barisano
Institutions
- Emory University (US)
- Center for Cancer and Blood Disorders (US)
- Children's Healthcare of Atlanta (US)
Publication Details
- Journal
- Cardiology in the Young
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1017/s1047951125101194
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00